We are live on ! Find out more
HEC

Hudson Executive Capital Portfolio holdings

AUM $151M
1-Year Est. Return 60.14%
This Fund
S&P 500
This Quarter Est. Return
+18.57%
1 Year Est. Return
+60.14%
3 Year Est. Return
+143.92%
5 Year Est. Return
+104.85%
10 Year Est. Return
+677.02%
AUM
$1.12B
AUM Growth
-$198M
Cap. Flow
-$348M
Cap. Flow %
-30.93%
Top 10 Hldgs %
100%
Holding
12
New
Increased
2
Reduced
1
Closed
4

Top Buys

Rank Stock Value
1
TVTY
Tivity Health, Inc. Common Stock
TVTY
+$8.14M
2
CTLP
Cantaloupe
CTLP
+$1.81M

Sector Composition

Rank Sector Weight
1 Financials 44.79%
2 Industrials 32.3%
3 Healthcare 9.71%
4 Technology 6.84%
5 Materials 3.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DB icon
1
Deutsche Bank
DB
$65.9B
$503M 44.79%
64,861,476
CATM
2
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$363M 32.3%
8,126,933
CTLP
3
DELISTED
Cantaloupe
CTLP
$76.8M 6.84%
10,385,172
+245,000
+2% +$1.81M
TVTY
4
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$56.6M 5.04%
2,781,655
+435,095
+19% +$8.14M
EGRX
5
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$39.8M 3.54%
661,897
-148,468
-18% -$8.85M
SMG icon
6
ScottsMiracle-Gro
SMG
$3.91B
$38.3M 3.4%
360,275
STOR
7
DELISTED
STORE Capital Corporation
STOR
$33.2M 2.95%
890,800
NTRA icon
8
Natera
NTRA
$37.5B
$12.8M 1.14%
378,589
ATRC icon
9
AtriCure
ATRC
$1.66B
-87,678
Closed -$2.19M
IWM icon
10
PUT
iShares Russell 2000 ETF
IWM
$81.2B
-557,000
Closed -$84.3M
SPY icon
11
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
-678,000
Closed -$201M
CVRS
12
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
-14,235,545
Closed -$60.9M

Similar funds

Hudson Executive Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Hudson Executive Capital held 12 positions worth $1.12B, down 15% from $1.32B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Hudson Executive Capital withdrew a net $348M in Q4 2019, closing 4 positions and reducing 1 holding. Its most notable exit was CORINDUS VASCULAR ROBOTICS, INC, an estimated $60.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 45% of assets, up from 37% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Hudson Executive Capital added an estimated $8.14M to Tivity Health, Inc. Common Stock.

  • Hudson Executive Capital added most to Tivity Health, Inc. Common Stock in Q4 2019, an estimated $8.14M increase.
  • Hudson Executive Capital's biggest Q4 2019 reduction was Eagle Pharmaceuticals, Inc., cutting an estimated $8.85M.
  • Hudson Executive Capital fully exited CORINDUS VASCULAR ROBOTICS, INC in Q4 2019, selling an estimated $60.9M.
  • Hudson Executive Capital's ten largest holdings make up 100% of its $1.12B portfolio in Q4 2019.
  • Hudson Executive Capital opened 0 new positions and closed 4 in Q4 2019.
  • Hudson Executive Capital's portfolio value fell 15% quarter-over-quarter to $1.12B.

Based on Hudson Executive Capital's 13F filing for Q4 2019, filed 14 Feb 2020.